Showing results (1761-1770 of 2,490) with videos related to

Sort By:
Pageof 249
Modern Rheumatology|July 7, 2017
Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritisYoshiya Tanaka, Tsutomu Takeuchi, Hisanori Umehara, et al.
Digestion|June 6, 2018
Usefulness of Demarcation of Differentiated-Type Early Gastric Cancers after Helicobacter pylori Eradication by Magnifying Endoscopy with Narrow-Band ImagingYoichi Akazawa, Hiroya Ueyama, Takashi Yao, et al.
The Review of Scientific Instruments|December 3, 2008
Radial density profile measurement by using the multichannel microwave interferometer in GAMMA 10M Yoshikawa, T Matsumoto, Y Shima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 30, 2019
[A Case of an Elderly with Locoregional Recurrence of ER-Negative HER2-Positive Breast Cancer Successfully Treated with Local Therapy]Setsuko Yoshioka, Shigeyuki Hojo, Yasuhiro Toyoda, et al.
Therapeutic Advances in Gastroenterology|November 26, 2020
Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infectionMariko Hojo, Daisuke Asaoka, Tsutomu Takeda, et al.
Neurochemistry International|August 29, 2017
Analysis of lipid raft molecules in the living brain slicesNorihiro Kotani, Takanari Nakano, Yui Ida, et al.
Hippokratia|October 6, 2015
Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in JapanA Nagahara, D Asaoka, M Hojo, et al.
Journal of Gastroenterology|December 1, 2017
Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND studyYoshikazu Kinoshita, Mototsugu Kato, Mitsuhiro Fujishiro, et al.
Journal of Radiation Research|May 24, 2018
Late radiological changes after passive scattering proton beam therapy for Stage I lung cancerNaoki Nakamura, Hidehiro Hojo, Kazuya Inoue, et al.
Digestion|June 13, 2017
A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional DyspepsiaMariko Hojo, Akihito Nagahara, Daisuke Asaoka, et al.
Pageof 249